Related Experiment Video

Updated: Sep 9, 2025

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.4K

Advancing Pediatric Hypertension: Mechanism Insights, Clinical Trials and Innovation

Monika Verma1, Smita Narwal1, Gurvirender Singh2

  • 1Global Research Institute of Pharmacy, Radaur, Yamuna Nagar, 135133, Haryana, India.

Current Hypertension Reviews
|September 5, 2025
PubMed

Insights

Pediatric hypertension is a growing concern linked to genetics and lifestyle. Early detection and tailored treatments, including lifestyle changes and medications, are crucial for managing childhood hypertension and preventing long-term cardiovascular issues.

Area of Science:

  • Pediatric Nephrology and Cardiology
  • Public Health and Epidemiology
  • Genetics and Environmental Health

Background:

  • Pediatric hypertension (PH) is a significant and increasing global health challenge.
  • Early-onset hypertension in children is linked to severe long-term cardiovascular complications.
  • Understanding the multifactorial etiology of PH is critical for effective management.

Purpose of the Study:

  • To provide a comprehensive overview of pediatric hypertension, covering its epidemiology, causes, and pathophysiology.
  • To review current treatment modalities and recent clinical studies on hypertension in children and adolescents.
  • To highlight key factors contributing to PH and discuss future research directions.

Main Methods:

  • A systematic literature search was performed across major scientific databases (PubMed, Scopus, Web of Science).
  • Inclusion criteria focused on high-quality, peer-reviewed studies, clinical trials, and reviews published within the last decade.
  • Keywords were specifically chosen to capture relevant research on pediatric hypertension.

Main Results:

  • Key etiological factors identified include genetic predisposition, renal artery stenosis, renin-angiotensin-aldosterone system (RAAS) activation, obesity, metabolic syndrome, and excessive sodium intake.
  • Treatment strategies encompass lifestyle modifications and pharmacological agents such as ACE inhibitors, calcium channel blockers, beta-blockers, and diuretics.
  • Recent clinical trials have yielded valuable data on the safety and efficacy of various therapeutic interventions.

Conclusions:

  • Effective management of pediatric hypertension necessitates prompt diagnosis and individualized treatment plans.
  • Future research should prioritize precision medicine approaches, long-term outcome data, and leveraging technology for surveillance.
  • Continued investigation is vital to address the rising prevalence and long-term impact of hypertension in pediatric populations.

Keywords:
Pediatric hypertensionclinical trials.epidemiologyhypertensionmanagementpathophysiology

More Related Videos

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets08:08

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Published on: May 11, 2015

14.3K
Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

308

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
48
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
73
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
42
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.1K
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
71
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
250